scholarly journals Gastric Cancer in Pregnancy

2019 ◽  
Vol 70 (7) ◽  
pp. 2681-2683
Author(s):  
Aneta Tomescu ◽  
Cezar Tomescu ◽  
Mariana Aschie ◽  
Gabriela Stanciu ◽  
Rodica Sirbu ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Pregnant Woman ◽  
Gestational Age ◽  
Pregnant Patient ◽  
Cancer In Pregnancy ◽  
In Pregnancy

Gastric cancer is an uncommon occurrence in pregnancy, but its prognosis is grim. The co-occurrence of these two symptoms makes it almost impossible for one to suspect a diagnosis of gastric cancer in a pregnant woman. Herein, we present the case of a pregnant patient, diagnosed with gastric cancer at a gestational age of 24 weeks.

424 Advanced gestational age is a predictor of non-completion of sleep apnea testing in pregnancy

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A168-A168
Author(s):  
Mihaela Bazalakova ◽  
Abigail Wiedmer ◽  
Lauren Rice ◽  
Sakshi Bajaj ◽  
Natalie Jacobson ◽  
...  
Keyword(s):  
Sleep Apnea ◽  
Gestational Age ◽  
Retrospective Chart Review ◽  
Pregnant Patient ◽  
Clinic Visit ◽  
Early Screening ◽  
Home Sleep Apnea Testing ◽  
Living Children ◽  
Apnea Testing ◽  
In Pregnancy

Abstract Introduction Sleep apnea is emerging as an important and underdiagnosed comorbidity in pregnancy. Screening, diagnosis, and initiation of therapy are all time-sensitive processes during the dynamic progression of gestation. Completion of referral and testing for sleep apnea during pregnancy requires a significant commitment of time and effort on the part of the pregnant patient. We evaluated for predictors of non-completion of sleep apnea testing within our obstetric-sleep referral pipeline, in an effort to inform and optimize future referrals. Methods We performed a retrospective chart-review of 405 pregnant patient referrals for sleep apnea evaluation at the University of Wisconsin-Madison/UnityPoint sleep apnea pregnancy clinic. We used logistic regression analysis to determine predictors of lack of completion of sleep apnea testing. Results The vast majority of referrals (>95%) were triaged directly to home sleep apnea testing with the Alice PDX portable device, rather than a sleep clinic visit. The overall rate of referral non-completion was 59%. Predictors of non-completion of sleep apnea evaluation in our pregnant population included higher gestational age (GA) at referral (1–12 wks GA: 30%, 13–26 wks GA: 31%, and 27–40 wks GA: 57% non-completers, p=0.006) and multiparity with 1 or more living children (65% non-completers if any living children, compared to 45% non-completers if no living children, p=0.002). Age, race, and transportation were not predictors of failure to complete sleep apnea testing. Conclusion We have identified several predictors of pregnant patients’ failure to complete sleep apnea evaluation with objective home sleep apnea testing after referral from obstetrics. Not surprisingly, higher gestational age emerged as a strong negative predictor of referral completion, with >50% of patients referred in the third trimester not completing sleep apnea testing. Early screening and referral for sleep apnea evaluation in pregnancy should be prioritized, given the time-sensitive nature of diagnosis and therapy initiation, and demonstrated reduced completion of referrals in advanced pregnancy. Support (if any) None

Birthweight and Chemotherapy Exposure in Women Diagnosed with Breast Cancer during Pregnancy

2020 ◽  
Author(s):  
Taylor S. Freret ◽  
Pedro Exman ◽  
Erica L. Mayer ◽  
Sarah E. Little ◽  
Katherine E. Economy
Keyword(s):  
Breast Cancer ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Chemotherapy Regimen ◽  
Small Sample ◽  
Maternal Outcomes ◽  
Z Score ◽  
Cancer In Pregnancy ◽  
Lower Birthweight ◽  
In Pregnancy

Objective Breast cancer is one of the most frequently diagnosed cancers in pregnancy and is commonly treated with chemotherapy. To date, studies examining effects of chemotherapy during pregnancy on fetal growth have yielded conflicting results, and most are limited by small sample sizes or are nonspecific with respect to cytotoxic regimen or type of cancer treated. We sought to evaluate the effect of chemotherapy for breast cancer in pregnancy on birthweight and small for gestational age infants. Study Design This is a retrospective cohort study of 74 women diagnosed with pathologically confirmed breast cancer during pregnancy between 1997 and 2018 at one of three academic medical centers, who had a singleton birth with known birthweight. Forty-nine received chemotherapy and 25 did not receive chemotherapy. Linear regression modeling was used to compare birthweight (by gestational age and sex-specific z-score) by chemotherapy exposure. Subanalyses of specific chemotherapy regimen and duration of chemotherapy exposure were also performed. Placental, neonatal, and maternal outcomes were also analyzed by chemotherapy exposure. Results In the adjusted model, chemotherapy exposure was associated with lower birthweight (∆ z-score =  − 0.49, p = 0.03), but similar rates of small for gestational age (defined as birthweight <10th percentile for gestational age) infants (8.2 vs. 8.0%, p = 1.0; Fisher’s exact test). Each additional week of chemotherapy (∆ z-score =  − 0.05, p = 0.03) was associated with decreased birthweight, although no association was found with specific chemotherapy regimen. Chemotherapy exposure was associated with lower median placental weight percentile by gestational age (9th vs. 75th, p < 0.05). Secondary maternal outcomes were similar between the group that did and did not receive chemotherapy. Conclusion Chemotherapy for breast cancer in pregnancy in this cohort is associated with lower birthweight but no difference in the rate of small for gestational age infants. Key Points

scholarly journals Successful Treatment of Gastric Cancer in Pregnancy

2009 ◽  
Vol 48 (3) ◽  
pp. 282-285 ◽  
Author(s):  
Masashi Yoshida ◽  
Hideo Matsuda ◽  
Kenichi Furuya
Keyword(s):  
Gastric Cancer ◽  
Successful Treatment ◽  
Cancer In Pregnancy ◽  
In Pregnancy

scholarly journals An Indonesian Pregnant Woman with Lung Cancer and Liver Metastasis : A Case Report

2018 ◽  
Vol 12 (2) ◽  
pp. 67
Author(s):  
Vito Filbert Jayalie ◽  
Dimas Priantono ◽  
Zulkifli Amin
Keyword(s):  
Lung Cancer ◽  
Pregnant Woman ◽  
Multidisciplinary Approach ◽  
Stage Iv ◽  
Small Cell ◽  
Shortness Of Breath ◽  
Special Issue ◽  
Small Cell Lung ◽  
Cancer In Pregnancy ◽  
In Pregnancy

Background: Lung cancer in pregnancy is a rare disease compared to other types of cancer. However, special issue should be applied in order to maximize benefit for mother without harming the fetus.Methods: We present a case of 37-year-old, five months pregnant woman who came to the hospital with chief complain of shortness of breath. Later on, she was found to have a stage IV Non-Small Cell Lung Cancer (NSCLC) with adenocarcinoma subtype.Result: This may be the first lung cancer in pregnancy reported in Indonesia. Being a developing country, several challenges emerged before diagnosing patient of having lung cancer.Conclusion: Careful considerations along with multidisciplinary approach are necessary to provide the best care for the patient.

scholarly journals A Case of Babesiosis in a Pregnant Patient Treated with Red Blood Cell Exchange Transfusion

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Baruch Abittan ◽  
Aaron Nizam ◽  
Michael Oey ◽  
Felicia Callan ◽  
Lisa Simmonds ◽  
...  
Keyword(s):  
United States ◽  
Blood Cell ◽  
Gestational Age ◽  
Red Blood Cell ◽  
Exchange Transfusion ◽  
Pregnant Patient ◽  
Babesia Microti ◽  
History Of ◽  
Safe Treatment Option ◽  
In Pregnancy

Babesiosis, caused predominantly by Babesia microti, is an emerging health risk in the Northeastern and Midwestern United States. We present a case of a pregnant woman with history of splenectomy diagnosed with babesiosis at 23 5/7 weeks of gestational age refractory to antimicrobial therapy. She underwent the first reported red blood cell exchange transfusion for babesiosis in pregnancy, at 24 4/7 weeks of gestational age, which resulted in resolution of parasitemia. She had a full term, uncomplicated cesarean delivery. Exchange transfusion is potentially a safe treatment option for severe babesiosis infection in pregnancy and should be considered when other methods are poorly tolerated or ineffective.

scholarly journals A rare case of vaginal sarcoma in pregnancy

2020 ◽  
Vol 9 (9) ◽  
pp. 3906
Author(s):  
Avinashi Kujur ◽  
Archana Roy ◽  
Suma Velgin Ekka ◽  
Divya Gupta
Keyword(s):  
Case Report ◽  
Pregnant Woman ◽  
Urinary Retention ◽  
Gestational Age ◽  
Rare Case ◽  
Rare Tumour ◽  
Vaginal Mass ◽  
Live Baby ◽  
In Pregnancy

Vaginal Sarcoma is an extremely rare tumour in pregnancy. Authors are presenting a case report of a pregnant woman who presented with vaginal mass and urinary retention at 32 weeks of gestational age. USG confirmed a live baby with possibility of cervical fibroid. Before further investigations for diagnosis of the mass her emergency LSCS has to be done. Histopathology and immunohistochemistry then confirmed sarcoma.

scholarly journals Microcirculation in Pregnancy

2014 ◽  
pp. 395-408 ◽  
Author(s):  
I. ABDO ◽  
R. B. GEORGE ◽  
M. FARRAG ◽  
V. CERNY ◽  
C. LEHMANN
Keyword(s):  
Pregnant Woman ◽  
Oxygen Supply ◽  
Pregnant Patient ◽  
Physiological Changes ◽  
Patient Will ◽  
Measurement And Evaluation ◽  
Physiological Systems ◽  
In Pregnancy

The microcirculation, like all physiological systems undergoes modifications during the course of pregnancy. These changes aid the adaption to the new anatomical and physiological environment of pregnancy and ensure adequate oxygen supply to the fetus. Even though the microcirculation is believed to be involved in major pregnancy related pathologies, it remains poorly understood. The availability of safe and non-interventional technologies enabling scientists to study the intact microcirculation of the pregnant patient will hopefully expand our understanding. In this article we review the physiological changes occurring in the microcirculation during pregnancy and the role of the microcirculation in gestational related pathologies. We will also describe the available techniques for the measurement and evaluation of the microcirculation. Lastly we will highlight the possible fields in which these techniques could be utilized to help provide a clearer view of the microcirculation in the pregnant woman.

scholarly journals Case Report: Gastric Carcinoma Diagnosed at the Second Trimester of Pregnancy

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Tayfur Cift ◽  
Begüm Aydogan ◽  
Murat Akbaş ◽  
Burcu Aydın ◽  
Fuat Demirkiran ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Differential Diagnosis ◽  
Case Report ◽  
Rare Case ◽  
Normal Pregnancy ◽  
Metastatic Gastric Cancer ◽  
Second Trimester ◽  
Cancer In Pregnancy ◽  
Very High ◽  
In Pregnancy

We report a rare case of gastric cancer in pregnancy. A 26-year-old woman presented at the 20th week of pregnancy complaining of nausea and vomiting. Although the patient considered the condition to be related with pregnancy and underestimated its importance, her complaints persisted over the following weeks and she was hospitalized for investigation. The diagnostic workup revealed a metastatic gastric cancer. Gastric cancer is very rare in pregnancy, and therefore it may be left out of differential diagnosis by physicians. Diagnosis may be further delayed because of overlapping symptoms occurring during normal pregnancy (nausea, vomiting, and fatigue). All these factors may contribute to a very high mortality of this malignancy during pregnancy.

Gastric cancer in pregnancy

2003 ◽  
Vol 82 (2) ◽  
pp. 207-208 ◽  
Author(s):  
I Ozdemir ◽  
M Pehlivan ◽  
F Demirci
Keyword(s):  
Gastric Cancer ◽  
Cancer In Pregnancy ◽  
In Pregnancy
Sign in / Sign up

Export Citation Format

Share Document